logo

Cocrystal Pharma, Inc. (COCP)



Trade COCP now with
  Date
  Headline
9/3/2019 8:28:54 AM Cocrystal Pharma Presents Positive Preclinical Data For CC-42344 At The Options X For Control Of Influenza Conference
8/21/2019 8:11:16 AM Cocrystal Pharma Says Abstract Accepted For Oral Presentation At ISIRV: Options X For Control Of Influenza Conference
1/22/2019 8:07:04 AM Cocrystal Pharma Provides Update On Clinical Development Program Evaluating CC-31244 For Ultra-Short Treatment Of HCV
1/3/2019 8:36:12 AM Cocrystal Pharma, Merck To Discover And Develop Certain Proprietary Influenza A/B Antiviral Agents
12/26/2018 12:40:01 AM 8 Biotech Stocks To Watch This Week
11/12/2018 8:12:28 AM Cocrystal Q3 Net Loss $1.87 Mln Vs Loss $2.26 Mln Last Year
10/8/2018 8:15:07 AM Cocrystal Pharma Announces Clinical Trial Deal For Investigator-Initiated Phase 2a Study In Hong Kong Of CC-31244
9/20/2018 8:08:40 AM Cocrystal Pharma Completes Patient Enrollment In Phase 2a Study Of CC-31244 For Ultra-Short Treatment Of Hepatitis C
  
 
>